Literature DB >> 82561

Cyclic GMP binding and cyclic GMP phosphodiesterase in rat platelets.

P Hamet, J F Coquil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 82561

Source DB:  PubMed          Journal:  J Cyclic Nucleotide Res        ISSN： 0095-1544


× No keyword cloud information.
  8 in total

Review 1.  Phosphodiesterase inhibitors.

Authors:  Victoria Boswell-Smith; Domenico Spina; Clive P Page
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

2.  GREBP, a cGMP-response element-binding protein repressing the transcription of natriuretic peptide receptor 1 (NPR1/GCA).

Authors:  Guy Martel; Pavel Hamet; Johanne Tremblay
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

Review 3.  Clinical and molecular genetics of the phosphodiesterases (PDEs).

Authors:  Monalisa F Azevedo; Fabio R Faucz; Eirini Bimpaki; Anelia Horvath; Isaac Levy; Rodrigo B de Alexandre; Faiyaz Ahmad; Vincent Manganiello; Constantine A Stratakis
Journal:  Endocr Rev       Date:  2013-12-05       Impact factor: 19.871

4.  Immunohistochemical localisation of PDE5 in Leydig and myoid cells of prepuberal and adult rat testis.

Authors:  Angela Scipioni; Stefania Stefanini; Rocco Santone; Mauro Giorgi
Journal:  Histochem Cell Biol       Date:  2005-11-03       Impact factor: 4.304

5.  The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors.

Authors:  D Salvemini; W Radziszewski; R Korbut; J Vane
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

6.  Reciprocal effects of an inhibitory factor on catalytic activity and noncatalytic cGMP binding sites of rod phosphodiesterase.

Authors:  A Yamazaki; F Bartucca; A Ting; M W Bitensky
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis.

Authors:  Sabrina Noel; Barbara Dhooghe; Teresinha Leal
Journal:  Front Pharmacol       Date:  2012-09-18       Impact factor: 5.810

8.  Vardenafil increases intracellular accumulation of the most prevalent mutant cystic fibrosis transmembrane conductance regulator (CTFR) in human bronchial epithelial cells.

Authors:  Barbara Dhooghe; Caroline Bouzin; Angélique Mottais; Emmanuel Hermans; Martial Delion; Nadtha Panin; Sabrina Noel; Teresinha Leal
Journal:  Biol Open       Date:  2020-08-25       Impact factor: 2.422
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.